River blindness: a devastating yet neglected tropical disease in Africa

Dear Editor, River blindness, also known as Onchocerciasis, is a Neglected Tropical Disease (NTD) that affects millions of people in Africa. It is caused by a parasitic nematode (Onchocerca volvulus) that is transmitted to humans through infected black flies. The disease is called river blindness since the black flies breed around fast-flowing rivers and streams, where people can often become exposed to the parasite through their bites[1]. The parasite then grows and reproduces in the human body, causing a range of clinical manifestations and in some cases, blindness (Fig. 1).Figure 1.: Illustration of Onchocerca volvulus life cycle. Blackfly (genus Simulium) takes a blood meal transmitting the larvae (Phase 1); Subcutaneous tissues and adult in subcutaneous nodule (Phase 2); adults produce unsheathed microfilariae (Phase 3); blackfly takes a blood meal ingesting microfilariae (Phase 4); L1 larvae (Phase 5); L3 larvae in blackfly which migrates to head and blackfly’s proboscis (Phase 6). This cycle occurs in 3 major phases: Onchocerca volvulus (Phase 1); human stage (Phases 2 and 3); blackfly stage (Phases 4, 5 and 6). Created in https://BioRender.com. Original Author: DPDx, Division of Parasitic Diseases and Malaria (DPDM). Image under public domain. Original image can be accessed from: http://dpd.cdc.gov/dpdx/HTML/ImageLibrary/Filariasis_il.htm. River blindness is endemic in 31 African countries and it is estimated that over 120 million people are at risk of contracting the disease[2]. It is primarily a problem in sub-Saharan Africa, where over 99% of the cases occur (Fig. 2). Additionally, it is particularly common in rural areas, where access to healthcare and preventive measures are limited[3].Figure 2.: Map of Africa (A) showing the 31 infected countries and encompassing 99% of cases (B). The symptoms of river blindness include intense itching, skin rashes and nodules under the skin. In severe cases, the disease can also lead to blindness[3]. It is the second leading infectious cause of blindness worldwide, following trachoma[4]. In addition to causing blindness, Onchocerciasis is associated with reduced life expectancy, increased mortality and the development of epiljpgy[5]. In Africa, many individuals affected by River Blindness also experience Loiasis, a filarial disease caused by the Loa Loa parasite. Loiasis is extremely common in two key areas known as the west and east foci of Africa[6]. The simultaneous presence of Onchocerciasis and Loiasis intensifies the overall burden of the diseases, necessitating the implementation of integrated methods to control them. The impacts of Onchocerciasis extend beyond physical health, affecting individuals psychosocially and economically. Infected individuals and their families often face social stigma as well as reduced earnings due to the inability to work. Manual labor compromises a large portion of the work force in African countries and it is affected by the physical debilitations of the disease. Communities may migrate away from fertile agricultural land to escape the vectors of the illness, decreasing agricultural yields and perpetuating poverty[5]. School-aged children affected by the disease may have poor academic performance and a high dropout rate. Healthcare access and infrastructure pose significant challenges in African regions affected by River Blindness. Remote and marginalized communities suffer from inadequate healthcare facilities, a shortage of trained medical professionals and insufficient resources to effectively prevent and treat the disease[7]. This limited access to healthcare services hinders timely diagnosis, treatment and ongoing care for affected individuals. The persistent transmission of the disease through the black flies also poses a major obstacle as it hinders the progress made through drug administration programs. The only preventative measures of the disease include the use of insect repellents and wearing loose-fitting clothing. There is no vaccine or drug to prevent an onchocerciasis infection, delaying elimination efforts[8]. River blindness is considered a NTD due to its debilitating nature that is overlooked by governing authorities. It primarily affects populations impacted by poverty thus leading to a lack of incentive for drug development[8]. Diagnosis of onchocerciasis remains a challenge and the NTD Diagnostics Technical Advisory Group identified development of new diagnostic tools for onchocerciasis a priority[7]. Furthermore, the unavailability of a vaccine or drug to prevent the disease emphasizes its classification as an NGT[8]. Significant progress has been made in controlling and eliminating river blindness in Africa, particularly through mass drug administration (MDA) campaigns. For example, programs coordinated by the WHO and the African Program for Onchocerciasis Control (APOC) have successfully reduced the prevalence of the disease in countries such as Uganda, where MDA combined with vector control (VC) has led to the interruption of transmission in several regions[9,10]. However, despite these successes, critical gaps remain in funding, awareness, and healthcare infrastructure, particularly in underserved rural areas. A recent analysis by Mutono et al[11] records reporting 10 or more years of continuous MDA with 80% or more therapeutic coverage of the eligible population yielded significantly higher odds of achieving elimination of transmission, the critical importance of sustained, high-coverage interventions in endemic regions. To eradicate River Blindness, a multi-faceted approach is required. It is crucial to address this issue promptly and effectively. The primary approach for achieving eradication is the continuation of the widespread distribution of ivermectin through MDA. Ivermectin targets and eliminates the microfilariae of O. volvulus present in the skin. Additionally, ivermectin may have the ability to kill or render the adult worms infertile[12]. MDA remains the cornerstone of onchocerciasis control and elimination efforts. These campaigns, coordinated by national health authorities, non-governmental organizations (NGOs), and international partnerships such as the WHO, aim to deliver annual or biannual doses of ivermectin to at-risk populations. For instance, a study conducted by Targema et al[13] indicated that the highest CFA prevalence rate recorded was 66% recorded at Ogi-Utonkon, Ado LGA, Benue State, NC. However, challenges such as low treatment adherence and logistical barriers in remote areas continue to impede progress. Addressing these challenges will require strengthening local healthcare infrastructure and integrating community engagement strategies. VC is a critical yet underutilized strategy in the fight against onchocerciasis. The WHO has emphasized its importance in reducing the spread of vector-borne NTDs[7]. A notable example is the success of larvicide programs in West Africa, where regular application of environmentally safe insecticides in breeding sites of black flies led to the near elimination of disease transmission in some river basins[14]. However, scaling up such initiatives requires substantial investment in infrastructure and training. Additionally, novel approaches, such as genetic modification of black fly populations to reduce their ability to transmit O. volvulus, are currently under investigation[7] and hold promise for long-term control. Furthermore, new strategies to prevent the transmission of the illness must be investigated and existing strategies must be monitored for progress. Awareness campaigns must also be launched across the continent to educate the public about the risk factors of the disease and its consequences. Those affected in rural areas should also have access to treatment in a prompt and efficient manner by improving access to health care facilities. In recent years, there has been progress in reducing its catastrophic consequences through the use of MDA programs, which provide medication to at-risk populations. Nevertheless, continued investment in research, treatment and prevention efforts are essential to ultimately eliminate the disease. International collaboration and funding are vital in the fight against River Blindness in Africa[15]. Many NGOs already provide financial and technical support to affected countries. These resources are used for drug procurement, capacity building, research and monitoring procedures. With such sustained efforts, River Blindness could soon be eliminated in numerous African countries.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.